A Study of Suvecaltamide in Adults With Moderate to Severe Residual Tremor in Parkinson's Disease
Completed · Phase 2 · Has a placebo group
Conditions studied: Parkinson Disease, Tremor
In brief
This is a 17-week double-blind, placebo-controlled, randomized, flexible-dosing, parallel-group, multicenter study designed to evaluate the efficacy and safety of suvecaltamide for the treatment of moderate to severe residual tremor in adult participants with Parkinson's disease (PD). The target population represents participants who have tremor that is not adequately controlled by PD medications and that interferes with their activities of daily living (ADL) and/or with their performance of tasks.
Key facts
- Study ID
- NCT05642442
- Run by
- Jazz Pharmaceuticals
- People needed
- 169
- Starts
- 2022-12-01
- Expected to finish
- 2024-11-11
- Last updated by the study team
- 2026-01-15
Who can join
Age: 40 and older, up to 85. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Movement Disorders Center of Arizona — Scottsdale, Arizona, United States
- Keck School of Medicine of University of Southern California (USC) — Los Angeles, California, United States
- University of Colorado Hospital Anschutz Outpatient Pavilion — Aurora, Colorado, United States
- Neurology of Central Florida Research Center LLC — Altamonte Springs, Florida, United States
- Parkinson's Disease and Movement Disorder Center of Boca Raton — Boca Raton, Florida, United States
- Clinical Neuroscience Solutions, Inc. — Jacksonville, Florida, United States
- USF Parkinson's Disease and Movement Disorders Center — Tampa, Florida, United States
- NeuroTrials Research Inc. — Atlanta, Georgia, United States
- Hawaii Pacific Health — Honolulu, Hawaii, United States
- Northwestern Medical Group, Department of Neurology — Chicago, Illinois, United States
- University of Kansas Medical Center — Kansas City, Kansas, United States
- University of Kentucky, College of Medicine, Department of Neurology — Lexington, Kentucky, United States
- The Nene and Jamie Koch Comprehensive Movement Disorders Center — Albuquerque, New Mexico, United States
- Albany Medical College — Albany, New York, United States
- Dent Neurologic Institute — Amherst, New York, United States
- Columbia University Irving Medical Center — New York, New York, United States
- South Shore Neurologic Associates PC — Patchogue, New York, United States
- University of Cincinnati Gardner Neuroscience Institute (UCGNI) — Cincinnati, Ohio, United States
- Vanderbilt University Medical Center — Nashville, Tennessee, United States
- Central Texas Neurology Consultants — Round Rock, Texas, United States
- EverGreenHealth Neuroscience Institute — Kirkland, Washington, United States
- Zentrum f. klinische Forschung Dr. I. Schöll — Bad Homburg, Germany
- Pharmakologisches Studienzentrum Chemnitz GmbH — Chemnitz, Germany
- Curiositas-ad-sanum Beratungs-und Studien GmbH — Haag in Oberbayern, Germany
- Deutsche Klinik fur Diagnostik Helios Klinik Wiesbaden — Hessen, Germany
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.